Printer Friendly

United States : Constipation Linked To Narcotic Use In Sickle Cell Patients.

Sickle cell patients receiving narcotic treatments may need to be better monitored for constipation

Individuals with sickle cell suffer from painful episodes caused by sickle cells that get caught in small blood vessels and result in blood flow blockage. The frequent use of narcotics in these patients, especially in young children, is effective, but leads to mild constipation.

In addition to discomfort, studies have found that this health complication can worsen the side effects of sickle cell disease. In an effort to reduce the chances of developing constipation, medical professionals have recommended giving these individuals laxatives and stool softeners.

During a one-year study, researchers observed hospitalized sickle cell patients who were treated with narcotics and compared it to the number of individuals who received treatments to prevent constipation.

The team discovered that approximately one-third of the patients who participated in the study were not given laxatives or stool samples.

Sarah O Brien, a researcher at Nationwide Children s Hospital in Ohio, stated that "the abdomen is a well-known site of sickle cell pain." She added that "abdominal pain due to constipation may be misinterpreted as a worsening sickle cell symptoms with subsequent higher doses of narcotics and therefore worsening constipation.

Copyright : Euclid Infotech Pvt. Ltd.

Provided by Syndigate.info an Albawaba.com company
COPYRIGHT 2010 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:TendersInfo
Article Type:Clinical report
Date:Jul 27, 2010
Words:213
Previous Article:United States : High voltage power line proposed between La Crosse and Madison.
Next Article:United States : Google Introduces a Dictionary OneBox.
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters